{"mainPropery":{"diseaseId":4421,"diseaseName":"Catecholaminergic polymorphic ventricular tachycardia","hasGardWebPage":true,"isRare":true,"websiteUrl":"https://rarediseases.info.nih.gov/diseases/4421/catecholaminergic-polymorphic-ventricular-tachycardia","synonyms":["Familial polymorphic ventricular tachycardia","Catecholamine-induced polymorphic ventricular tachycardia","CPVT","Syncopal paroxysmal tachycardia","Polymorphic catecholergic ventricular tachycardia","Stress-induced polymorphic ventricular tachycardia","Bidirectional tachycardia induced by catecholamine","Double tachycardia induced by catecholamines","Malignant paroxysmal ventricular tachycardia","Multifocal ventricular premature beats"],"synonyms-with-source":[{"name":"Familial polymorphic ventricular tachycardia"},{"name":"Catecholamine-induced polymorphic ventricular tachycardia"},{"name":"CPVT","source":""},{"name":"Syncopal paroxysmal tachycardia"},{"name":"Polymorphic catecholergic ventricular tachycardia"},{"name":"Stress-induced polymorphic ventricular tachycardia"},{"name":"Bidirectional tachycardia induced by catecholamine"},{"name":"Double tachycardia induced by catecholamines"},{"name":"Malignant paroxysmal ventricular tachycardia"},{"name":"Multifocal ventricular premature beats"}],"identifiers":[{"identifierType":"OMIM","identifierId":"604772"},{"identifierType":"ORPHANET","identifierId":"3286"}]},"diseaseCategories":[{"diseaseTypeId":5,"diseaseTypeName":"Congenital and Genetic Diseases","source":"Orphanet"},{"diseaseTypeId":4,"diseaseTypeName":"Heart Diseases","source":"Orphanet"}],"organizations":[],"resource descriptions":[{"id":7,"resourceId":10,"resourceName":"Online Mendelian Inheritance in Man (OMIM)","descriptionText":"<a href='http://www.omim.org/604772' target='_blank'>Online Mendelian Inheritance in Man (OMIM)</a> is a catalog of human genes and genetic disorders. Each entry has a summary of related medical articles. It is meant for health care professionals and researchers. OMIM is maintained by Johns Hopkins University School of Medicine.&nbsp;<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":8,"resourceId":11,"resourceName":"PubMed","descriptionText":"<a href='http://www.ncbi.nlm.nih.gov/pubmed?term=Polymorphic%20catecholergic%20ventricular%20tachycardia' target='_blank'>PubMed</a> is a searchable database of medical literature and lists journal articles that discuss Catecholaminergic polymorphic ventricular tachycardia. Click on the link to view a sample search on this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":9,"resourceId":12,"resourceName":"ClinicalTrials.gov","descriptionText":"<a href='http://www.clinicaltrials.gov/ct2/results?cond=%22Polymorphic+catecholergic+ventricular+tachycardia%22' target='_blank'>ClinicalTrials.gov</a> lists trials that are related to Catecholaminergic polymorphic ventricular tachycardia. Click on the link to go to ClinicalTrials.gov to read descriptions of these studies. <br />\r\n<br />\r\n<em><strong>Please note:</strong>&nbsp;Studies listed on the&nbsp;ClinicalTrials.gov&nbsp;website are listed for informational purposes only; being listed does not reflect an endorsement by GARD or the NIH. We strongly recommend that you talk with a trusted healthcare provider before choosing to participate in any clinical study.</em>","resourceClassificationName":"Research","resourceClassificationSectionName":"Clinical Research Resources"},{"id":10,"resourceId":13,"resourceName":"MedlinePlus Genetics","descriptionText":"<a href='http://ghr.nlm.nih.gov/condition/catecholaminergic-polymorphic-ventricular-tachycardia' target='_blank'>Genetics Home Reference (GHR)</a> contains information on Catecholaminergic polymorphic ventricular tachycardia. This website is maintained by the National Library of Medicine.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1457,"resourceId":2104,"resourceName":"Genetic Services","descriptionText":"To find a medical professional who specializes in genetics, you can ask your doctor for a referral or you can search for one yourself. Online directories are provided by the <a href='http://www.acmg.net/ACMG/Genetic_Services_Directory_Search.aspx' target='_blank'>American College of Medical Genetics</a> and the&nbsp;<a href='https://www.findageneticcounselor.com/' target='_blank'>National Society of Genetic Counselors</a>. If you need additional help, <a href=\"https://rarediseases.info.nih.gov/about-gard/contact-gard\">contact a GARD Information Specialist</a>. You can also&nbsp;<a href='https://ghr.nlm.nih.gov/primer#consult' target='_blank'>learn more about genetic consultations</a>&nbsp;from Genetics Home Reference.","resourceClassificationName":"Find a Specialist","resourceClassificationSectionName":"Healthcare Resources"},{"id":1526,"resourceId":2158,"resourceName":"Genetic Testing Registry","descriptionText":"The <a href='http://www.ncbi.nlm.nih.gov/gtr/conditions/C1631597' target='_blank'>Genetic Testing Registry</a> (GTR) provides information about the genetic tests for this condition. The intended audience for the GTR is health care providers and researchers. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.<br />\r\n","resourceClassificationName":"Diagnosis","resourceClassificationSectionName":"Testing Resources"},{"id":1531,"resourceId":2162,"resourceName":"Medscape Reference","descriptionText":"<a href='http://emedicine.medscape.com/article/159075-overview' target='_blank'>Medscape Reference</a> provides information on this topic. You may need to register to view the medical textbook, but registration is free.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1534,"resourceId":2165,"resourceName":"Orphanet","descriptionText":"<a href='http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=3286' target='_blank'>Orphanet</a> is a European reference portal for&nbsp;information on rare diseases and orphan drugs. Access to this database is free of charge.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1537,"resourceId":2168,"resourceName":"GeneReviews","descriptionText":"<a href='http://www.ncbi.nlm.nih.gov/books/NBK1289/' target='_blank'>GeneReviews</a> provides current, expert-authored, peer-reviewed, full-text articles describing the application of genetic testing to the diagnosis, management, and genetic counseling of patients with specific inherited conditions.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1538,"resourceId":2169,"resourceName":"MeSH®","descriptionText":"<a href='http://www.nlm.nih.gov/cgi/mesh/2013/MB_cgi?mode=&index=228418&view=expanded' target='_blank'>MeSH®</a> (Medical Subject Headings) is a terminology tool used by the National Library of Medicine. Click on the link to view information on this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1542,"resourceId":2170,"resourceName":"RePORTER","descriptionText":"The <a href='http://projectreporter.nih.gov/reporter.cfm' target='_blank'>Research Portfolio Online Reporting Tool (RePORT)</a> provides access to reports, data, and analyses of research activities at the National Institutes of Health (NIH), including information on NIH expenditures and the results of NIH-supported research.  Although these projects may not conduct studies on humans, you may want to contact the investigators to learn more. To search for studies, enter the disease name in the \"Text Search\" box.  Then click \"Submit Query\".","resourceClassificationName":"Research","resourceClassificationSectionName":"Clinical Research Resources"},{"id":1705,"resourceId":2846,"resourceName":"Project OrphanAnesthesia","descriptionText":"<a href='http://www.orphananesthesia.eu/en/rare-diseases/published-guidelines/cat_view/61-rare-diseases/60-published-guidelines/137-catecholaminergic-polymorphic-ventricular-tachycardia.html' target='_blank'>Project OrphanAnesthesia</a> is a project whose aim is to create peer-reviewed, readily accessible guidelines for patients with rare diseases and for the anesthesiologists caring for them. The project is a collaborative effort of the German Society of Anesthesiology and Intensive Care, Orphanet, the European Society of Pediatric Anesthesia, anesthetists and rare disease experts with the aim to contribute to patient safety.","resourceClassificationName":"Treatment","resourceClassificationSectionName":"Management Guidelines"},{"id":2135,"resourceId":3342,"resourceName":"Monarch Initiative","descriptionText":"The <a href='https://monarchinitiative.org/disease/OMIM:611938' target='_blank'>Monarch Initiative</a> brings together data about this condition from humans and other species to help physicians and biomedical researchers. Monarch&rsquo;s tools are designed to make it easier to compare the signs and symptoms (phenotypes) of different diseases and discover common features. This initiative is a collaboration between several academic institutions across the world and is funded by the National Institutes of Health. Visit the website to explore the biology of this condition.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"}],"overviewQuestion":{"questionId":6704,"questionText":"What is catecholaminergic polymorphic ventricular tachycardia?","answerText":"<strong>Catecholaminergic polymorphic ventricular tachycardia</strong> (CPVT) is&nbsp;a genetic disorder that causes an abnormally fast and irregular&nbsp;heart rhythm in response to physical activity or emotional stress. Signs and symptoms include light-headedness, dizziness, and fainting. Symptoms most often develop between 7 to 9 years of age. &nbsp;If untreated CPVT can cause a heart attack and death. CPVT&nbsp;is caused by mutations in the <em><a href=\"http://ghr.nlm.nih.gov/gene/RYR2\" target=\"_blank\">RYR2</a></em>&nbsp;or <a href=\"http://ghr.nlm.nih.gov/gene/CASQ2\" target=\"_blank\"><em>CASQ2</em></a> genes. When&nbsp;a <em>RYR2 </em>gene mutation is involved, the&nbsp;condition&nbsp;is passed through families in an <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002049.htm\" target=\"_blank\">autosomal dominant</a> fashion. When&nbsp;<em>CASQ2 </em>gene mutations are involved, the condition is inherited in an&nbsp;<a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002052.htm\" target=\"_blank\">autosomal recessive</a> fashion.[5794] In some cases the underlying cause can not be determined.&nbsp;<a href=\"http://www.heart.org/HEARTORG/Encyclopedia/Heart-Encyclopedia_UCM_445084_Encyclopedia.jsp?levelSelected=2&amp;title=beta%20blockers\" target=\"_blank\">Beta blockers</a> are used to treat CPVT. &nbsp;An&nbsp;<a href=\"http://www.heart.org/HEARTORG/Conditions/Arrhythmia/PreventionTreatmentofArrhythmia/Implantable-Cardioverter-Defibrillator-ICD_UCM_448478_Article.jsp\" target=\"_blank\">Implantable Cardioverter Defibrillator (ICD)</a>&nbsp;may also be needed.&nbsp;","dateModified":"2013-01-25T13:40:00"},"basicQuestions":[{"questionId":6706,"questionText":"Do all people with catecholaminergic polymorphic ventricular tachycardia&nbsp;require treatment?","answerText":"It has been recommended that all people clinically diagnosed with catecholaminergic polymorphic ventricular tachycardia (CPVT)&nbsp;receive treatment.&nbsp;Some individuals who have never had or demonstrated symptoms of CPVT, for example asymptomatic family members with&nbsp;<em>CASQ2 </em>gene mutations,&nbsp;may still benefit from treatment.[5797] We recommend that you speak with your healthcare provider&nbsp;regarding your treatment options.","dateModified":"2013-01-25T15:55:00","resourceClassificationName":"Treatment","references":[{"referenceId":5797,"authors":"Buxton A","articleTitle":"Catecholaminergic polymorphic ventricular tachycardia and other polymorphic ventricular tachycardias with a normal QT interval","bookWebsiteJournalTitle":"UpToDate","date":"2012","authors2":"Basow, DS (Ed)","placeOfPublication":"Waltham, MA","publisher":"UpToDate"}]}],"references":[],"relatedDiseases":[{"relatedDiseaseId":12619,"relatedDiseaseName":"Arrhythmia syndrome","relation":"Parent","isRare":false,"hasGardPage":false},{"relatedDiseaseId":2263,"relatedDiseaseName":"Familial ventricular tachycardia","relation":"Child","isRare":true,"hasGardPage":true}],"gardCases":[{"caseId":37875,"abbreviatedInquiry":"I have been diagnosed with&nbsp;CPVT. I've been off medication for a few years and have been playing sports regularly.&nbsp;&nbsp;I've never had any syncope. I&nbsp;just read that&nbsp;if untreated CPVT is highly lethal. And now I'm starting to care.&nbsp;I have some questions about this disease:&nbsp;Is there any case of remission? Is it curable?&nbsp;Are sports under treatment better than without treatment?&nbsp;Is there a CPVT specialist anywhere in the world?&nbsp;What is the most up-to-date article/research about this disease?","caseQuestions":[{"questionId":6705,"questionText":"Can catecholaminergic polymorphic ventricular tachycardia go into remission?","answerText":"In medicine the word \"remission\" is often used to refer to a condition where there is no evidence of ongoing disease activity.&nbsp;The signs and symptoms of catecholaminergic polymorphic ventricular tachycardia (CPVT)&nbsp;are typically not constant,&nbsp;but&nbsp;serious concern is warranted&nbsp;for&nbsp;sudden CPVT events that may be triggered by activity or emotional stress. It has been estimated that 83% of&nbsp;people with CPVT&nbsp;will experience CPVT related symptoms. Symptoms of CPVT often present in childhood (75% by age 20),[5795][5796] however&nbsp;CPVT has presented&nbsp;in older adults&nbsp;as well.[5796]&nbsp;<br>","dateModified":"2013-01-25T15:13:00","references":[{"referenceId":5795,"authors":"Pflaumer A, Davis AM","articleTitle":"Guidelines for the diagnosis and management of catecholaminergic polymorphic ventricular tachycardia","bookWebsiteJournalTitle":"Heart, Lung and Circulation","date":"February 2012;21(2):96-100","url":"http://www.ncbi.nlm.nih.gov/pubmed/22119737","dateAccessed":"2013-01-25T00:00:00"},{"referenceId":5796,"authors":"Napolitano C, Priori SG, Bloise R","articleTitle":"Catecholaminergic polymorphic ventricular tachycardia","bookWebsiteJournalTitle":"GeneReviews","date":"October 14, 2004","url":"http://www.ncbi.nlm.nih.gov/books/NBK1289/","dateAccessed":"2013-01-25T00:00:00"},{"referenceId":5797,"authors":"Buxton A","articleTitle":"Catecholaminergic polymorphic ventricular tachycardia and other polymorphic ventricular tachycardias with a normal QT interval","bookWebsiteJournalTitle":"UpToDate","date":"2012","authors2":"Basow, DS (Ed)","placeOfPublication":"Waltham, MA","publisher":"UpToDate"}]},{"questionId":6706,"questionText":"Do all people with catecholaminergic polymorphic ventricular tachycardia&nbsp;require treatment?","answerText":"It has been recommended that all people clinically diagnosed with catecholaminergic polymorphic ventricular tachycardia (CPVT)&nbsp;receive treatment.&nbsp;Some individuals who have never had or demonstrated symptoms of CPVT, for example asymptomatic family members with&nbsp;<em>CASQ2 </em>gene mutations,&nbsp;may still benefit from treatment.[5797] We recommend that you speak with your healthcare provider&nbsp;regarding your treatment options.","dateModified":"2013-01-25T15:55:00","resourceClassificationName":"Treatment","references":[{"referenceId":5797,"authors":"Buxton A","articleTitle":"Catecholaminergic polymorphic ventricular tachycardia and other polymorphic ventricular tachycardias with a normal QT interval","bookWebsiteJournalTitle":"UpToDate","date":"2012","authors2":"Basow, DS (Ed)","placeOfPublication":"Waltham, MA","publisher":"UpToDate"}]},{"questionId":6707,"questionText":"Can people with catecholaminergic polymorphic ventricular tachycardia play sports?","answerText":"It has been generally recommended that young people with genetic heart disease be \"cautioned against virtually all forms of vigorous physical activity.\"[5795] We recommend that you speak with your healthcare provider for further&nbsp;advice regarding your activities and&nbsp;restrictions.","dateModified":"2013-01-25T15:29:00","references":[{"referenceId":5795,"authors":"Pflaumer A, Davis AM","articleTitle":"Guidelines for the diagnosis and management of catecholaminergic polymorphic ventricular tachycardia","bookWebsiteJournalTitle":"Heart, Lung and Circulation","date":"February 2012;21(2):96-100","url":"http://www.ncbi.nlm.nih.gov/pubmed/22119737","dateAccessed":"2013-01-25T00:00:00"}]},{"questionId":6708,"questionText":"How might catecholaminergic polymorphic ventricular tachycardia be treated?","answerText":"Treatment of&nbsp;adults with catecholaminergic polymorphic ventricular tachycardia (CPVT)&nbsp;related arrhythmias typically involves&nbsp;the use of <a href=\"http://www.mayoclinic.com/health/beta-blockers/HI00059\" target=_blank>beta blockers</a>. An <a href=\"http://www.nhlbi.nih.gov/health/health-topics/topics/icd/\" target=_blank>implantable cardioverter-defibrillator</a> (ICD) and beta blocker treatment may be considered for people with&nbsp;CPVT who have experienced a heart attack,&nbsp;fainting spells, or sustained&nbsp;abnormal heart rhythms on beta blockers alone.&nbsp;If these individuals still&nbsp;experience heart rhythm abnormalities&nbsp;flecainide and/or verapamil may also be recommended. People whose condition&nbsp;remains resistant to therapy&nbsp;may be counseled regarding further treatment options, such as&nbsp;left <a href=\"http://www.mayoclinic.org/medicalprofs/videoscopic-denervation.html\" target=_blank>sympathetic denervation</a>.[5797]&nbsp;<br><br>GeneReviews provides a current, expert-authored, peer-reviewed, full-text articles which includes information on treatment of CPVT at the following link:&nbsp;<br><a href=\"http://www.ncbi.nlm.nih.gov/books/NBK1289/#cvt.Management\">http://www.ncbi.nlm.nih.gov/books/NBK1289/#cvt.Management</a>","dateModified":"2013-01-25T15:50:00","resourceClassificationName":"Treatment","references":[{"referenceId":5797,"authors":"Buxton A","articleTitle":"Catecholaminergic polymorphic ventricular tachycardia and other polymorphic ventricular tachycardias with a normal QT interval","bookWebsiteJournalTitle":"UpToDate","date":"2012","authors2":"Basow, DS (Ed)","placeOfPublication":"Waltham, MA","publisher":"UpToDate"}]},{"questionId":6709,"questionText":"Can catecholaminergic polymorphic ventricular tachycardia be cured?","answerText":"Effective treatments are available for&nbsp;catecholaminergic polymorphic ventricular tachycardia, however there is&nbsp;currently no&nbsp;targeted treatment that can cure CPVT at this time.&nbsp;","dateModified":"2013-01-25T15:38:00","resourceClassificationName":"Treatment","references":[]},{"questionId":6710,"questionText":"Are there any research studies involving catecholaminergic polymorphic ventricular tachycardia?","answerText":"Yes. To learn more about research studies and clinical trials involving catecholaminergic polymorphic ventricular tachycardia, please visit the Clinical Trials &amp; Research tab at the following link:<br><a href=\"http://www.rarediseases.info.nih.gov/GARD/Condition/4421/Catecholamineinduced_polymorphic_ventricular_tachycardia.aspx\" target=_blank>http://www.rarediseases.info.nih.gov/GARD/Condition/4421/Catecholamineinduced_polymorphic_ventricular_tachycardia.aspx</a>","dateModified":"2013-01-25T15:39:00","references":[]},{"questionId":6711,"questionText":"How can I find catecholaminergic polymorphic ventricular tachycardia experts?","answerText":"While we do not have a list of doctors who specialize in treating catecholaminergic polymorphic ventricular tachycardia, we have developed&nbsp;the following&nbsp;information page titled, <a href=\"http://rarediseases.info.nih.gov/GARD/FindAnExpert.aspx\" target=_blank>How To Find An Expert</a>&nbsp;that has tips for finding knowledgable professionals, and may be a helpful resource.","dateModified":"2013-01-25T15:40:00","references":[]}]}],"news":[{"newsId":671,"dateCreated":"2020-05-20T13:39:00","publishDate":"2020-05-22T00:00:00","title":"NIH-Supported Research Survey to Examine Impact of COVID-19 on Rare Diseases Community","description":"The NIH-funded Rare Diseases Clinical Research Network (RDCRN) has launched an <a href=\"https://www.rarediseasesnetwork.org/COVIDsurvey \" target=\"_blank\">online research survey</a> to find out how the COVID-19 pandemic is impacting individuals with rare diseases, their families and their caregivers. Your participation can help the rare disease research community shed light on the needs of people with rare diseases during this and other potential health crises, in addition to informing future research efforts. The survey must be completed by December 15, 2020.","url":"https://www.rarediseasesnetwork.org/COVIDsurvey","lastModified":"2020-11-30T14:44:00","isFeatured":false}],"conferences":[],"phenoTypes":[{"phenoTypeId":9930,"phenoTypeName":"Ventricular tachycardia","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":11411,"phenoTypeName":"Vertigo","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":9135,"phenoTypeName":"Atrial fibrillation","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":12076,"phenoTypeName":"Atrial standstill","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":8977,"phenoTypeName":"Sudden cardiac death","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":9376,"phenoTypeName":"Syncope","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":13489,"phenoTypeName":"Abnormal left ventricular function","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":6539,"phenoTypeName":"Autosomal dominant inheritance","percentRanges":"-"},{"phenoTypeId":8719,"phenoTypeName":"Seizure","percentRanges":"-"},{"phenoTypeId":9007,"phenoTypeName":"Sudden death","percentRanges":"-"}],"medicalProducts":[{"productId":64,"genericName":"Sotalol HCl","tradeName":"Betapace","tradeLink":"","manufacturer":"","sponsor":"Berlex Laboratories, Inc.","indication":"Treatment of life-threatening ventricular tachyarrhythmias.","drugInformationLink":"https://druginfo.nlm.nih.gov/drugportal/name/betapace","medlinePlusLink":"https://medlineplus.gov/druginfo/meds/a693010.html"},{"productId":490,"genericName":"Amiodarone HCl","tradeName":"Cordarone®","tradeLink":"http://www.wyeth.com/products","manufacturer":"Wyeth Pharmaceuticals, Inc.","sponsor":"Wyeth-Ayerst Laboratories","indication":"For initiation of treatment and prophylaxis of frequently recurring ventricular fibrillation and hemodynamically unstable ventricular tachycardia in patients refractory to other therapy.","drugInformationLink":"http://druginfo.nlm.nih.gov/drugportal/dpdirect.jsp?name=Cordarone","medlinePlusLink":"http://www.nlm.nih.gov/medlineplus/druginfo/meds/a687009.html"}],"EncodedName":"Catecholaminergic_polymorphic_ventricular_tachycardia"}